Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Obesity Surgery
Published in: Obesity Surgery 1/2021

01-01-2021 | Obesity | Review

Gut Microbiota in Patients with Morbid Obesity Before and After Bariatric Surgery: a Ten-Year Review Study (2009–2019)

Authors: Spyridon G. Koulas, Christos K. Stefanou, Stefanos K. Stefanou, Kostas Tepelenis, Nikolaos Zikos, Konstantinos Tepetes, Andreas Kapsoritakis

Published in: Obesity Surgery | Issue 1/2021

Login to get access

Abstract

The changes in the composition and function of gut microbiota affect the metabolic functions (which are mediated by microbial effects) in patients with obesity, resulting in significant physiological regulation in these patients. Most of the studies emphasize that the Western-style diet (high fat and low vegetable consumption) leads to significant changes in the intestinal microbiome in individuals with metabolic syndrome. A deeper understanding of the profiles of gut microbes will contribute to the development of new therapeutic strategies for the management of metabolic syndrome and other metabolic diseases and related disorders. The aim of this review is to evaluate recent experimental evidence outlining the alterations of gut microbiota composition and function in recovery from bariatric surgical operations with an emphasis on sleeve gastrectomy and gastric bypass.
Literature
1.
Booijink CC, et al., Microbial communities in the human small intestine: coupling diversity to metagenomics. 2007.
2.
Ventura M, et al., Microbial diversity in the human intestine and novel insights from metagenomics. 2009.
3.
4.
Turroni F, Ribbera A, Foroni E, et al. Human gut microbiota and Bifidobacteria: from composition to functionality. Antonie Van Leeuwenhoek. 2008;94(1):35–50.PubMedCrossRef
5.
Salonen A, Palva A, de Vos WM. Microbial functionality in the human intestinal tract. Front Biosci. 2009;14:3074–84.CrossRef
6.
Fraher MH, O’toole PW, Quigley EM. Techniques used to characterize the gut microbiota: a guide for the clinician. Nat Rev Gastroenterol Hepatol. 2012;9(6):312–22.PubMedCrossRef
7.
8.
Tremaroli V, BÃckhed F. Functional interactions between the gut microbiota and host metabolism. Nature. 2012;489(7415):242.PubMedCrossRef
9.
10.
Dong TS, Gupta A. Influence of early life, diet, and the environment on the microbiome. Clin Gastroenterol Hepatol. 2018;
11.
Membrez M, Blancher F, Jaquet M, et al. Gut microbiota modulation with norfloxacin and ampicillin enhances glucose tolerance in mice. FASEB J. 2008;22(7):2416–26.PubMedCrossRef
12.
Cani PD, Bibiloni R, Knauf C, et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet induced obesity and diabetes in mice. Diabetes. 2008;57(6):1470–81.PubMedCrossRef
13.
Delzenne NM, Neyrinck AM, Bäckhed F, et al. Targeting gut microbiota in obesity: effects of prebiotics and probiotics. Nat Rev Endocrinol. 2011;7(11):639–46.PubMedCrossRef
14.
Cani PD, Lecourt E, Dewulf EM, et al. Gut microbiota fermentation of prebiotics increases satietogenic and incretin gut peptide production with consequences for appetite sensation and glucose response after a meal. Am J Clin Nutr. 2009;90(5):1236–43.PubMedCrossRef
15.
16.
17.
den Besten G, van Eunen K, Groen AK, et al. The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res. 2013;54(9):2325–40.CrossRef
18.
Bindels LB, Porporato P, Dewulf EM, et al. Gut microbiota-derived propionate reduces cancer cell proliferation in the liver. Br J Cancer. 2012;107(8):1337–44.PubMedPubMedCentralCrossRef
19.
Tan J, et al., The role of short-chain fatty acids in health and disease, in Advances in immunology. 2014, Elsevier. p. 91–119.
20.
21.
22.
Turnbaugh PJ et al. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444(7122):1027.PubMedCrossRef
23.
Duncan SH, Lobley GE, Holtrop G, et al. Human colonic microbiota associated with diet, obesity and weight loss. Int J Obes. 2008;32(11):1720–4.CrossRef
24.
Ussar S, Griffin NW, Bezy O, et al. Interactions between gut microbiota, host genetics and diet modulate the predisposition to obesity and metabolic syndrome. Cell Metab. 2015;22(3):516–30.PubMedPubMedCentralCrossRef
25.
Vijay-Kumar M, Aitken JD, Carvalho FA, et al. Metabolic syndrome and altered gut microbiota in mice lacking toll-like receptor 5. Science. 2010;328(5975):228–31.PubMedPubMedCentralCrossRef
26.
Di Luccia B et al. Rescue of fructose-induced metabolic syndrome by antibiotics or faecal transplantation in a rat model of obesity. PLoS One. 2015;10(8):e0134893.PubMedPubMedCentralCrossRef
27.
Haro C, Garcia-Carpintero S, Alcala-Diaz JF, et al. The gut microbial community in metabolic syndrome patients is modified by diet. J Nutr Biochem. 2016;27:27–31.PubMedCrossRef
28.
Le Chatelier E et al. Richness of human gut microbiome correlates with metabolic markers. Nature. 2013;500(7464):541–6.PubMedCrossRef
29.
30.
Qin J, Li Y, Cai Z, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60.PubMedCrossRef
31.
Sandoval D. Bariatric surgeries: beyond restriction and malabsorption. Int. J. Obes. (Lond.). 2011;35(Suppl. 3):S45–9.CrossRef
32.
Li JV, Ashrafian H, Bueter M, et al. Metabolic surgery profoundly influences gut microbial host metabolic cross-talk. Gut. 2011;60(9):1214–23.PubMedCrossRef
33.
Osto M, Abegg K, Bueter M, et al. Roux-en-Y gastric bypass surgery in rats alters gut microbiota profile along the intestine. Physiol Behav. 2013;119:92–6.PubMedCrossRef
34.
Guo Y, Liu CQ, Shan CX, et al. Gut microbiota after Roux en Y gastric bypass and sleeve gastrectomy in a diabetic rat model: increased diversity and associations of discriminant genera with metabolic changes. Diabetes Metab Res Rev. 2017;33(3):e2857.CrossRef
35.
Shao Y, Ding R, Xu B, et al. Alterations of gut microbiota after Roux-en-Y gastric bypass and sleeve gastrectomy in Sprague-Dawley rats. Obes Surg. 2017;27(2):295–302.PubMedCrossRef
36.
Liou AP et al. Conserved shifts in the gut microbiota due to gastric bypass reduce host weight and adiposity. Science Translational Medicine. 2013;5(178):178ra41.PubMedPubMedCentralCrossRef
37.
Jahansouz C, Staley C, Bernlohr DA, et al. Sleeve gastrectomy drives persistent shifts in the gut microbiome. Surg Obes Relat Dis. 2017;13(6):916–24.PubMedCrossRef
38.
39.
Furet J-P, Kong LC, Tap J, et al. Differential adaptation of human gut microbiota to bariatric surgery induced weight loss: links with metabolic and low-grade inflammation markers. Diabetes. 2010;59(12):3049–57.PubMedPubMedCentralCrossRef
40.
Kong L-C, Tap J, Aron-Wisnewsky J, et al. Gut microbiota after gastric bypass in human obesity: increased richness and associations of bacterial genera with adipose tissue genes. Am J Clin Nutr. 2013;98(1):16–24.PubMedCrossRef
41.
Palleja A, Kashani A, Allin KH, et al. Roux-en-Y gastric bypass surgery of morbidly obese patients induces swift and persistent changes of the individual gut microbiota. Genome medicine. 2016;8(1):67.PubMedPubMedCentralCrossRef
42.
Aron-Wisnewsky J, Prifti E, Belda E, et al. Major microbiota dysbiosis in severe obesity: fate after bariatric surgery. Gut. 2019;68(1):70–82.PubMedCrossRef
43.
Graessler J, Qin Y, Zhong H, et al. Metagenomic sequencing of the human gut microbiome before and after bariatric surgery in obese patients with type 2 diabetes: correlation with inflammatory and metabolic parameters. The Pharmacogenomics Journal. 2013;13(6):514–22.PubMedCrossRef
44.
Murphy R, Tsai P, Jüllig M, et al. Differential changes in gut microbiota after gastric bypass and sleeve gastrectomy bariatric surgery vary according to diabetes remission. Obes Surg. 2017;27(4):917–25.PubMedCrossRef
45.
Tremaroli V, Karlsson F, Werling M, et al. Roux-en-Y gastric bypass and vertical banded gastroplasty induce long-term changes on the human gut microbiome contributing to fat mass regulation. Cell Metab. 2015;22(2):228–38.PubMedPubMedCentralCrossRef
46.
Seeley RJ, Chambers AP, Sandoval DA. The role of gut adaptation in the potent effects of multiple bariatric surgeries on obesity and diabetes. Cell Metab. 2015;21(3):369–78.PubMedPubMedCentralCrossRef
47.
Li J et al. Experimental bariatric surgery in rats generates a cytotoxic chemical environment in the gut contents. Front Microbiol. 2011;2:183.PubMedPubMedCentral
48.
Carvalho B et al. Modulation of gut microbiota by antibiotics improves insulin signalling in high-fat fed mice. Diabetologia. 2012;55(10):2823–34.PubMedCrossRef
49.
Jones ML, Martoni CJ, Ganopolsky JG, et al. The human microbiome and bile acid metabolism: dysbiosis, dysmetabolism, disease and intervention. Expert Opin Biol Ther. 2014;14(4):467–82.PubMedCrossRef
50.
Everard A, Belzer C, Geurts L, et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc Natl Acad Sci. 2013;110(22):9066–71.PubMedCrossRefPubMedCentral
51.
Liu R, Hong J, Xu X, et al. Gut microbiome and serum metabolome alterations in obesity and after weight-loss intervention. Nat Med. 2017;23(7):859–68.PubMedCrossRef
52.
Guo Y, Huang ZP, Liu CQ, et al. Modulation of the gut microbiome: a systematic review of the effect of bariatric surgery. Eur J Endocrinol. 2018;178(1):43–56.PubMedCrossRef
53.
Magouliotis DE, Tasiopoulou VS, Sioka E, et al. Impact of bariatric surgery on metabolic and gut microbiota profile: a systematic review and meta-analysis. Obes Surg. 2017;27(5):1345–57.PubMedCrossRef
54.
Jahansouz C, Staley C, Kizy S, et al. Antibiotic-induced disruption of intestinal microbiota contributes to failure of vertical sleeve gastrectomy. Ann Surg. 2019;269(6):1092–100.PubMedCrossRef
55.
Damms-Machado A, Mitra S, Schollenberger AE, et al. Effects of surgical and dietary weight loss therapy for obesity on gut microbiota composition and nutrient absorption. Biomed Res Int. 2015;2015:1–12.CrossRef
56.
57.
Zhang X, Wang Y, Zhong M, et al. Duodenal-jejunal bypass preferentially elevates serum taurine- conjugated bile acids and alters gut microbiota in a diabetic rat model. Obes Surg. 2016;26(8):1890–9.PubMedCrossRef
58.
Baud G, Daoudi M, Hubert T, et al. Bile diversion in roux-en-Y gastric bypass modulates sodium-dependent glucose intestinal uptake. Cell Metab. 2016;23(3):547–53.PubMedCrossRef
59.
Sachdev S, Wang Q, Billington C, et al. FGF 19 and bile acids increase following Roux-en-Y gastric bypass but not after medical management in patients with type 2 diabetes. Obes Surg. 2016;26(5):957–65.PubMedPubMedCentralCrossRef
60.
Zhong M-W, Liu SZ, Zhang GY, et al. Alterations in gut microbiota during remission and recurrence of diabetes after duodenal-jejunal bypass in rats. World J Gastroenterol. 2016;22(29):6706.PubMedPubMedCentralCrossRef
61.
Woodard GA, Encarnacion B, Downey JR, et al. Probiotics improve outcomes after roux-en-Y gastric bypass surgery: a prospective randomized trial. J Gastrointest Surg. 2009;13(7):1198–204.PubMedCrossRef
62.
63.
Gralka E, Luchinat C, Tenori L, et al. Metabolomic fingerprint of severe obesity is dynamically affected by bariatric surgery in a procedure-dependent manner. Am J Clin Nutr. 2015;102(6):1313–22.PubMedCrossRef
64.
65.
Kelly CJ, Zheng L, Campbell EL, et al. Crosstalk between microbiota-derived short-chain fatty acids and intestinal epithelial HIF augments tissue barrier function. Cell Host Microbe. 2015;17(5):662–71.PubMedPubMedCentralCrossRef
66.
Saad M, Santos A, Prada P. Linking gut microbiota and inflammation to obesity and insulin resistance. Physiology. 2016;31(4):283–93.PubMedCrossRef
67.
Basso N, Soricelli E, Castagneto-Gissey L, et al. Insulin resistance, microbiota, and fat distribution changes by a new model of vertical sleeve gastrectomy in obese rats. Diabetes. 2016;65(10):2990–3001.PubMedCrossRef
68.
Clemente-Postigo M, Roca-Rodriguez MM, Camargo A, et al. Lipopolysaccharide and lipopolysaccharide-binding protein levels and their relationship to early metabolic improvement after bariatric surgery. Surg Obes Relat Dis. 2015;11(4):933–9.PubMedCrossRef
69.
Rothschild D, Weissbrod O, Barkan E, et al. Environment dominates over host genetics in shaping human gut microbiota. Nature. 2018;555:210–5.PubMedCrossRef
70.
71.
Schroeder BO, Birchenough GMH, Stahlman M, et al. Bifidobacteria or fiber protects against diet-induced microbiota-mediated colonic mucus deterioration. Cell Host & Microbe. 2018;23(1):27–40. e7CrossRef
72.
Zou J, Chassaing B, Singh V, et al. Fiber-mediated nourishment of gut microbiota protects against diet-induced obesity by restoring IL-22-mediated colonic health. Cell Host & Microbe. 2018;23(1):41–53. e4CrossRef
73.
Thompson SV, Hannon BA, An R, et al. Effects of isolated soluble fiber supplementation on body weight, glycemia, and insulinemia in adults with overweight and obesity: a systematic review and meta-analysis of randomized controlled trials. Am J Clin Nutr. 2017;106(6):1514–28.PubMedCrossRef
74.
Martel J, Ojcius DM, Chang CJ, et al. Anti-obesogenic and antidiabetic effects of plants and mushrooms. Nat Rev Endocrinol. 2017;13(3):149–60.PubMedCrossRef
75.
Zhang X, Zhao Y, Xu J, et al. Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats. ScientiPic Reports. 2015;5:14405.CrossRef
76.
77.
Vindigni SM, Surawicz CM. Fecal microbiota transplantation. Gastroenterol Clin N Am. 2017;46:171–85.CrossRef
78.
79.
Kriss M, Hazleton KZ, Nusbacher NM, et al. Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery. Curr Opin Microbiol. 2018;44:34–40.PubMedPubMedCentralCrossRef
80.
Vrieze A, Van Nood E, Holleman F, et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology. 2012;143:913–6.PubMedCrossRef
81.
Rowland I, Gibson G, Heinken A, et al. Gut microbiota functions: metabolism of nutrients and other food components. Eur J Nutr. 2018;57:1–24.PubMedCrossRef
82.
Baxter NT, Schmidt AW, Venkataraman A, et al. Dynamics of human gut microbiota and short-chain fatty acids in response to dietary interventions with three fermentable fibers. MBio. 2019;10:e02566–18.PubMedPubMedCentralCrossRef
83.
Tolhurst G, Heron H, Lam YS, et al. Short-chain fatty acids stimulate glucagon-like peptide-1 secretion via the G-protein-coupled receptor FFAR2. Diabetes. 2012;61:364–71.PubMedPubMedCentralCrossRef
84.
McNabney, S.M.; Henagan, T.M. Short chain fatty acids in the colon and peripheral tissues: a focus on butyrate, colon cancer, obesity and insulin resistance. Nutrients 2017, 9.
85.
86.
De Vadder F, Kovatcheva-Datchary P, Goncalves D, et al. Microbiota-generated metabolites promote metabolic benefits via gut brain neural circuits. Cell. 2014;156:84–96.CrossRefPubMed
87.
Smits LP, Kootte RS, Levin E, Prodan A, Fuentes S, Zoetendal EG, Wang Z, Levison B, Cleophas MCP, Kemper EM et al. Effect of vegan fecal microbiota transplantation on carnitine- and choline-derived trimethylamine-n-oxide production and vascular inflammation in patients with metabolic syndrome. J Am Heart Assoc 2018, 7.
88.
89.
Kootte RS, Levin E, Salojarvi J, et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition. Cell Metab. 2017;26:611–9.PubMedCrossRef
90.
Shin NR, Lee JC, Lee HY, et al. An increase in the Akkermansia spp. population induced by metformin treatment improves glucose homeostasis in diet-induced obese mice. Gut. 2014;63:727–35.PubMedCrossRef
91.
Dao MC, Everard A, Aron-Wisnewsky J, et al. Akkermansia muciniphila and improved metabolic health during a dietary intervention in obesity: relationship with gut microbiome richness and ecology. Gut. 2016;65:426–36.PubMedCrossRef
92.
Plovier H, Everard A, Druart C, et al. A purified membrane protein from Akkermansia muciniphila or the pasteurized bacterium improves metabolism in obese and diabetic mice. Nat Med. 2017;23:107–13.PubMedCrossRef
93.
Lynch KE, Parke EC, O’Malley MA. How causal are microbiomes? A comparison with the Helicobacter pylori explanation of ulcers. Bioi. Philos. 2019, pitt philsci, 15777.
94.
Armour CR, Nayfach S, Pollard KS, Sharpton Tj. A metagenomic meta-analysis reveals functional signatures of health and disease in the human gut microbiome. mSystems 2019,4.
95.
Metadata
Title
Gut Microbiota in Patients with Morbid Obesity Before and After Bariatric Surgery: a Ten-Year Review Study (2009–2019)
Authors
Spyridon G. Koulas
Christos K. Stefanou
Stefanos K. Stefanou
Kostas Tepelenis
Nikolaos Zikos
Konstantinos Tepetes
Andreas Kapsoritakis
Publication date
01-01-2021
Publisher
Springer US
Published in
Obesity Surgery / Issue 1/2021
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-020-05074-2

Other articles of this Issue 1/2021

Obesity Surgery 1/2021 Go to the issue

Original Contributions

Transversus Abdominis Plane Block in Laparoscopic Bariatric Surgery—a Systematic Review and Meta-Analysis of Randomized Controlled Trials

Letter to the Editor

A Curious Case of a Staple Line Leak Presenting 18 Months After Sleeve Gastrectomy: Our Management Approach

Multimedia Article

A Step-by-Step Surgical Technique Video of Revision of Roux-en-Y Gastric Bypass with Limb Distalization

Review

Measuring Muscle Mass and Strength in Obesity: a Review of Various Methods

Letter to the Editor

Bariatric and Metabolic Surgery Can Prevent People with Obesity from COVID-19 Infection

Original Contributions

Effects of Probiotics Supplementation on Gastrointestinal Symptoms and SIBO after Roux-en-Y Gastric Bypass: a Prospective, Randomized, Double-Blind, Placebo-Controlled Trial